Análisis retrospectivo en pacientes con cáncer de vesícula biliartratamiento quirúrgico y supervivencia en función del estadio tumoral

  1. Iago Justo Alonso 1
  2. Alberto A. Marcacuzco Quinto 1
  3. Oana Anisa Nutu 1
  4. Alejandro Manrique Municio 1
  5. Jorge Calvo Pulido 1
  6. Óscar Caso 1
  7. Félix Cambra Molero 1
  8. Álvaro García-Sesma Pérez-F 1
  9. Luis Carlos Jiménez Romero 1
  1. 1 Hospital Universitario 12 de Octubre
    info

    Hospital Universitario 12 de Octubre

    Madrid, España

    ROR https://ror.org/00qyh5r35

Journal:
Revista Española de Enfermedades Digestivas

ISSN: 2340-416 1130-0108

Year of publication: 2018

Volume: 110

Issue: 8

Pages: 485-492

Type: Article

More publications in: Revista Española de Enfermedades Digestivas

Abstract

Introduction: gallbladder cancer is the most common biliary neoplasm and the sixth most common tumor of the digestive system. The disease has an ominous prognosis, with a 5-year survival rate of approximately 5%. It is usually diagnosed late and surgical resection is the only potential cure. Methods: a retrospective study was carried out in 92 patients with a pathological diagnosis of gallbladder cancer from January 2000 to January 2016. Results: the mean age of cases was 72 ± 11 years; 64 subjects were females and 28 were males. Symptoms at admission included abdominal pain (78%), anorexia (77%), nausea (76%) and jaundice (45%). Surgery was indicated in 92 (100%) patients and 59 (64%) underwent a curative/intent resection. The initial surgical procedures included simple cholecystectomy in 69 (75%) cases and extended cholecystectomy in eleven (11%) subjects. Rescue surgery was performed in 15 patients with tumor tissue in the cholecystectomy specimen; ten individuals underwent an R0 curative resection. Adjuvant therapy was administered in 30 (33%) patients. The median survival in our series was 12.5 months, with survival rates of 57%, 30% and 20% at one, three and five years, respectively. Conclusion: to conclude, surgical treatment with a complete tumor resection should be considered for all patients, provided that their clinical status allows it.